Literature DB >> 18996032

Long-term results of arthrocentesis in degenerative temporomandibular disorders.

M Ercüment Onder1, Hakan H Tüz, Doruk Koçyiğit, Reha S Kişnişci.   

Abstract

OBJECTIVES: Long-term efficacy of arthrocentesis was investigated in patients with degenerative temporomandibular disorder (TMD) in this clinical study. STUDY
DESIGN: Twenty-two joints of 15 patients with degenerative TMD were included as the study group, and 16 joints of 10 patients served as the control group. Arthrocentesis procedures in upper joint spaces were performed. The study group patients' mean follow-up period was 36.7 +/- 18.7 months, whereas the control group were kept for an average 9.9 +/- 2.8 months. Results were statistically compared using 1-way repeated analysis of variance and t test.
RESULTS: Pretreatment maximal interincisal opening increased significantly from 33.6 +/- 6.0 mm to 37.8 +/- 6.0 mm in the study group. Pretreatment pain and crepitus scores decreased significantly from 71.0 +/- 6.6 to 27.0 +/- 16 and 0.73 +/- 0.4 to 0.6 +/- 0.5, respectively, in the study group.
CONCLUSIONS: Arthrocentesis was found to be a useful method for the treatment of degenerative TMDs, and the outcomes of treatment provide long-term cure for degenerative temporomandibular joints.

Entities:  

Mesh:

Year:  2008        PMID: 18996032     DOI: 10.1016/j.tripleo.2008.08.015

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  2 in total

1.  Arthrocentesis A Minimally Invasive Method for TMJ Disc Disorders - A Prospective Study.

Authors:  Vidya Kodage Chandrashekhar; Umesh Kenchappa; Sangamesh Ningappa Chinnannavar; Sarabjeet Singh
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 2.  Use of autologous conditioned serum (Orthokine) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature.

Authors:  Juan-Carlos Alvarez-Camino; Eduardo Vázquez-Delgado; Cosme Gay-Escoda
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.